Tenon Medical Q2 EPS $(0.33) Beats $(0.38) Estimate, Sales $743.00K Miss $1.00M Estimate
Portfolio Pulse from vinayak@benzinga.com
Tenon Medical (NASDAQ:TNON) reported Q2 EPS of $(0.33), beating the estimate of $(0.38) by 13.16%. However, the company's sales of $743.00K missed the estimate of $1.00M by 25.70%. Despite the miss, this represents a 450.37% increase in sales compared to the same period last year.
August 08, 2023 | 8:27 pm
News sentiment analysis
Sort by:
Ascending
NEUTRAL IMPACT
Tenon Medical's Q2 earnings beat estimates but sales missed. The sales still represent a significant YoY increase.
Tenon Medical's EPS beat estimates, which is a positive signal. However, the company missed on sales, which could be a concern for investors. Despite the miss, the YoY increase in sales is significant, which could offset some of the negative impact of the sales miss.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100